Concepedia

Rimke Oostvogels

RO

Statistics

Publications

16

Citations

695

H-Index

12

Active since

2012

Affiliations

University Medical Center Utrecht(Current)

Leiden University Medical Center

Amsterdam UMC Location Vrije Universiteit Amsterdam

Amsterdam University Medical Centers

Maastricht University

Rimke Oostvogels is an author at University Medical Center Utrecht specializing in oncology, immunotherapy, and immunology.

ORCID

Publications per year

2012–2024

16

Publications

16

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

Ajai Chari, Mehmet Samur, Joaquín Martínez‐López et al. · Blood · 2020 · 188 citations · Full text

, , +13

RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor

Zsolt Sebestyén, Wouter Scheper, Anna Vyborova et al. · Cell Reports · 2016 · 120 citations · Full text

, , +13

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study

Mirian Brink, Frederik O. Meeuwes, Marjolein van der Poel et al. · Blood · 2022 · 70 citations · Full text

, , +11

Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma

Inger S. Nijhof, Laurens E. Franssen, Mark‐David Levin et al. · Blood · 2016 · 56 citations · Full text

, , +14

Altered Peptide Ligands Revisited: Vaccine Design through Chemically Modified HLA-A2–Restricted T Cell Epitopes

Rieuwert Hoppes, Rimke Oostvogels, Jolien J. Luimstra et al. · The Journal of Immunology · 2014 · 46 citations · Full text

, , +17

1–5 of 16